Just In

Outsmarting Shape-Shifting Lung Cancer Resistance

Targeted ADCs For Advanced Lung Cancer

How Immunotherapy Unmasks Invisible Lung Cancer

Hacking the Lung Cancer Genetic Code

ASCO 2026 May 30th Program Highlights: Immunotherapy Advances in Solid Tumors

The ASCO 2026 May 30th program focused on immunotherapy in solid tumors, presenting data on novel combinations and biomarker-driven strategies.

HER2-Expressing Breast Cancer: Advancements in Targeted Therapies

New therapeutic strategies for HER2-expressing breast cancer presented at ASCO 2026 demonstrate improved outcomes across disease stages.

AI Foundation Models Enhance Diagnostic Insights in Oncology

AI foundation models presented at ASCO 2026 demonstrate potential to improve diagnostic precision and challenge existing oncology paradigms.

Cancer Elimination at ASCO 2026: Aspirational Goals and Current Realities

ASCO 2026 will address cancer elimination, focusing on prevention, early detection, and treatment advancements. Current evidence suggests a multi-faceted approach is necessary.

TRUQAP + Fulvestrant: 2L Option for HR+/HER2- aBC/mBC with PI3K-AKT Alterations

TRUQAP with fulvestrant offers a second-line treatment for HR+/HER2- advanced or metastatic breast cancer with specific PI3K-AKT pathway alterations.

Inluriyo™ and Verzenio® Presentations at ASCO 2026

Upcoming ASCO 2026 presentations will detail imlunestrant and abemaciclib, offering new data on endocrine therapy for breast cancer.

CELMoDs Show Promise in Relapsed/Refractory Multiple Myeloma

Emerging CELMoD research at ASCO 2026 highlights novel therapeutic strategies for relapsed/refractory multiple myeloma, addressing evolving patient needs.

ASCO 2026 May 29th Program Highlights: Novel Oncology Therapies

The ASCO 2026 May 29th program focused on advancements in targeted therapies and immunotherapies across various cancer types, presenting data on efficacy and safety.

Radiopharmaceutical Therapy: Improving Effectiveness, Access, and Safety

Radiopharmaceutical therapy (RPT) offers targeted cancer treatment, but challenges in efficacy, patient access, and risk mitigation persist.

Symptom Science Integration Improves Cancer Outcomes at ASCO 2026

Translating symptom science into clinical practice demonstrably improves patient outcomes in oncology, as highlighted at ASCO 2026.

Novel Biomarkers Improve Pediatric Solid Tumor Detection

New biomarkers enhance early detection and risk stratification in pediatric solid tumors, offering potential for more targeted therapeutic strategies.

Immunotherapy and Targeted Therapy: New Data from ASCO 2026

New research from ASCO 2026 explores combination strategies for advanced cancers and a machine learning approach to immunotherapy target discovery.

ICI Dissemination Challenges Highlighted at ASCO 2026

Global disparities in immune checkpoint inhibitor access and toxicity management were a key focus at ASCO 2026, revealing persistent implementation gaps.

Cancer Care Disparities Highlighted in Crisis, Displaced Populations

ASCO 2026 discussions underscore significant challenges in delivering equitable cancer care during crises and to immigrant and displaced populations.

The GLP-1 Muscle Loss Dilemma

The Velvet Rope Of Weight Loss Drugs

GLP-1 Drugs Protect Hearts And Kidneys

Rewiring The Brain To Silence Food Noise

Is It Safe To Switch Biosimilars?

Why Half Of Psoriasis Patients Quit

Psoriasis Monitoring Landscape Guide

Epigenetic Modifications Link Genes to Health Outcomes

Scientists link genetics to health through epigenetic modifications, specifically DNA methylation and histone deacetylases, influencing disease.

Patients Trust Google Over AI for Cancer Data, Doctors See AI Use for Patient Education

Patients prefer traditional search engines for health information, while physicians consider AI chatbots useful for patient education.

No Evidence Your Eyes Explain Overall Health in Recent Research

Recent research abstracts do not provide evidence linking ocular health to overall systemic health, focusing instead on unrelated topics.

Replacing Biologic Injections With Oral Pills

Yoga Reduces Insomnia, Fatigue, Anxiety in Cancer Survivors

A new study presented at ASCO 2026 demonstrates yoga significantly improves insomnia, fatigue, and anxiety in cancer survivors.

Doctor Attrition Linked to Moral Injury and Systemic Pressures

Dedicated doctors are leaving medicine due to moral injury from systemic pressures, impacting patient care and workforce stability.

Unilateral Strength Training Offers Distinct Advantages for GPs

Unilateral strength training addresses bilateral deficits, enhances stability, and can aid rehabilitation, offering distinct advantages over bilateral methods.

Surgery Linked to Slight Cognitive Decline in Older Adults

Older adults undergoing surgery may experience a small but measurable decline in cognitive function, warranting careful preoperative assessment.

Tricuspid Valve Surgery Benefits Adults with Systemic Right Ventricle

Adults with transposition of the great arteries (TGA) and systemic morphologic right ventricle (SRV) often develop SRV failure and tricuspid regurgitation (TR). A new study investigates the impact of tricuspid valve surgery (TVS) on clinical outcomes in this population.

Top Three Treatments for Eosinophilic Esophagitis Dysphagia Relief

Proton pump inhibitors, topical corticosteroids, and dietary elimination are primary treatments for EoE dysphagia, targeting inflammation and symptoms.

Dual Plane Block May Cut Opioid Use After Bypass Surgery

A dual plane block technique for coronary artery bypass grafting (CABG) may reduce postoperative opioid consumption.

Biologics Offer Targeted Efficacy in Psoriasis Management

Biologic therapies have significantly advanced psoriasis treatment by targeting specific immune pathways, offering improved outcomes for patients.

Four Lifestyle Factors Add a Year to Life Expectancy

Adopting four fundamental lifestyle habits can extend life expectancy by approximately one year, offering a clear, actionable pathway for patients.

Colonoscopy Beyond 75: Risks May Outweigh Benefits for Average-Risk Patients

The utility of routine colonoscopy in individuals over 75 years warrants re-evaluation due to increased procedural risks and diminishing benefits.

CAR T-Cell Therapy Shows Efficacy in Refractory Autoimmune Disease

CAR T-cell therapy, traditionally for cancer, demonstrates potential in severe autoimmune conditions, offering a new therapeutic avenue.

Antihypertensive Use Linked to Higher Fall Risk Across Patient Groups

Antihypertensive medications are associated with an increased fall risk across various patient demographics, necessitating careful risk-benefit assessment.

Tree Nut Allergy Prevalence in Dutch Children: A Review

A review of established medical knowledge indicates that tree nut allergies are a significant concern in pediatric populations, necessitating precise diagnostic and management strategies.

Patient Trust in Doctor Advice Declines: Survey Highlights Concerns

A recent survey indicates a decline in patient trust regarding medical advice, with implications for adherence and health outcomes.

Genital Lesions Most Common Sign of Chronic Candidiasis

Genital lesions are the most frequently observed clinical manifestation of chronic candidiasis disease (CCD), requiring careful differential diagnosis.

Myasthenia Gravis in Pregnancy: Exacerbations Common in Peripartum

Myasthenia gravis (MG) in pregnancy presents diagnostic and management challenges, with exacerbations common in the first trimester and postpartum period.

mRNA Shot Shows Efficacy Against Influenza-Like Illness

An mRNA vaccine demonstrated efficacy against influenza-like illness, offering a potential new approach to seasonal respiratory virus prevention.

Alternaria Allergy in Youth Signals Persistent Asthma Risk

Early sensitization to Alternaria alternata in children and adolescents is a significant predictor of asthma persistence into adulthood.

FDA Approves OTC Switch for Topical Adapalene 0.1% Gel

The FDA has approved the first over-the-counter retinoid, adapalene 0.1% gel, for acne treatment, expanding access to a previously prescription-only therapy.